Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

West Pharmaceutical Services Inc. buy UBS Group AG

West Pharmaceutical Services Inc.
Start price
€310.00
12.12.24 / 50%
Target price
€372.22
12.12.25
Performance (%)
-33.39%
Price
€206.30
07.08.25
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for West Pharmaceutical Services Inc. is performing very badly with a performance of -33.39%. Dividends of €0.20 are taken into consideration when calculating the performance. This prediction currently runs until 12.12.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
West Pharmaceutical Services Inc. -1.527% -1.527%
iShares Core DAX® 0.683% 0.785%
iShares Nasdaq 100 -1.457% 3.734%
iShares Nikkei 225® 0.931% 2.958%
iShares S&P 500 -2.022% 2.444%

Comments by UBS_Group_AG for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) -33.39%
Target price 372.216
Change
Ends at 12.12.25

West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $390.00 price target on the stock, up previously from $350.00.
Ratings data for WST provided by MarketBeat

UBS Group AG 
0
Report Share
12.12.24

Stopped prediction by UBS_Group_AG for West Pharmaceutical Services Inc.

buy
West Pharmaceutical Services Inc.

Start price
Target price
Perf. (%)
€226.50
25.07.25
€272.54
25.07.26
-8.92%
07.08.25

UBS Group AG 
25.07.25 50%